TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $34,000 | -51.4% | 70,501 | +34.9% | 0.00% | – |
| Q1 2019 | $70,000 | +250.0% | 52,247 | +194.0% | 0.00% | – |
| Q4 2018 | $20,000 | -83.5% | 17,769 | -59.4% | 0.00% | – |
| Q3 2018 | $121,000 | +764.3% | 43,774 | +1029.7% | 0.00% | – |
| Q2 2018 | $14,000 | -85.6% | 3,875 | -87.7% | 0.00% | – |
| Q1 2018 | $97,000 | -77.9% | 31,494 | -54.6% | 0.00% | – |
| Q4 2017 | $438,000 | -42.1% | 69,441 | -37.1% | 0.00% | -100.0% |
| Q3 2017 | $756,000 | +8.9% | 110,461 | +13.4% | 0.00% | 0.0% |
| Q2 2017 | $694,000 | -33.5% | 97,397 | -14.1% | 0.00% | 0.0% |
| Q1 2017 | $1,043,000 | +666.9% | 113,441 | +236.7% | 0.00% | – |
| Q4 2016 | $136,000 | +13500.0% | 33,688 | +14675.4% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 228 | -58.4% | 0.00% | – |
| Q2 2016 | $2,000 | -96.0% | 548 | -95.6% | 0.00% | – |
| Q1 2016 | $50,000 | -20.6% | 12,397 | +97.6% | 0.00% | – |
| Q4 2015 | $63,000 | -54.7% | 6,273 | -68.5% | 0.00% | – |
| Q3 2015 | $139,000 | -73.9% | 19,919 | +75.7% | 0.00% | -100.0% |
| Q2 2015 | $532,000 | +32.0% | 11,335 | +1.4% | 0.00% | – |
| Q1 2015 | $403,000 | -42.7% | 11,174 | -37.9% | 0.00% | -100.0% |
| Q4 2014 | $703,000 | +4921.4% | 18,008 | +2356.8% | 0.00% | – |
| Q3 2014 | $14,000 | +180.0% | 733 | +83.2% | 0.00% | – |
| Q2 2014 | $5,000 | -97.6% | 400 | -98.1% | 0.00% | – |
| Q1 2014 | $207,000 | +6800.0% | 20,743 | +6955.4% | 0.00% | – |
| Q4 2013 | $3,000 | -40.0% | 294 | -31.9% | 0.00% | – |
| Q3 2013 | $5,000 | +25.0% | 432 | -28.5% | 0.00% | – |
| Q2 2013 | $4,000 | – | 604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |